Position in BMY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$81,475,140
+$8,505,125 QoQ
Shares Held
1,414,008
+17.5% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#121
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. BMY ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
357,284 | $428,537,182 | |
| 2 | JNJ |
Johnson & Johnson
|
1,192,228 | $302,790,144 | |
| 3 | ABBV |
AbbVie Inc.
|
680,811 | $171,319,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,305,364 | $167,739,274 | |
| 5 | PFE |
Pfizer Inc
|
6,943,719 | $167,204,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
1,414,008 | $81,475,140 | |
| 7 | AMGN |
Amgen Inc
|
209,837 | $75,986,174 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
525,655 | $66,411,252 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,475,140 | 1,414,008 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $72,970,015 | 1,203,133 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $63,658,153 | 1,180,166 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $51,542,264 | 1,142,844 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $49,728,374 | 1,074,279 | Shares | Defined | 2025-12-02 | |
| 2025-03-31 | $57,221,793 | 938,216 | Shares | Sole | 2025-12-02 | |
| 2024-12-31 | $50,405,932 | 891,194 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $24,690,897 | 477,211 | Shares | Sole | 2025-12-09 | |
| 2024-06-30 | $20,982,575 | 505,239 | Shares | Defined | 2025-12-09 | |
| 2024-03-31 | $29,641,250 | 546,584 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $28,883,116 | 562,914 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $25,386,869 | 437,403 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $25,801,586 | 403,465 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $31,074,860 | 448,346 | Shares | Sole | 2025-12-09 | |
| 2022-12-31 | $35,035,619 | 486,944 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $39,307,793 | 552,930 | Shares | Sole | 2025-12-09 | |
| 2022-06-30 | $43,243,816 | 561,608 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $35,148,096 | 481,283 | Shares | Defined | 2025-12-09 | |
| 2021-12-31 | $29,082,409 | 466,438 | Shares | Defined | 2025-12-29 | |
| 2021-09-30 | $26,610,464 | 449,729 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $29,020,794 | 434,313 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $26,865,981 | 425,566 | Shares | Sole | 2025-12-29 | |
| 2020-12-31 | $26,678,420 | 430,089 | Shares | Sole | 2025-12-29 | |
| 2020-09-30 | $18,959,818 | 314,477 | Shares | Defined | 2025-12-29 | |
| 2020-06-30 | $16,329,641 | 277,715 | Shares | Sole | 2025-12-29 | |
| 2020-03-31 | $18,525,745 | 332,360 | Shares | Defined | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||